MP16-08 RE-EVALUATION OF INTRAVESICAL GEMCITABINE IN BACILLUS CALMETTE-GUERIN UNRESPONSIVE NON-MUSCLE INVASIVE BLADDER CANCER
2021
INTRODUCTION AND OBJECTIVE:Recently, bacillus Calmette Guerin (BCG) unresponsive criteria was established based on expert opinion to facilitate single arm Phase II/III trials for patients with NMIB...
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI